AI
RAPT

Alphabet Inc’s RAPT Therapeutics RAPT Stock Holding History

Alphabet Inc’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-67,534
Closed -$1.09M – 39
2024
Q3 		$1.09M Hold
67,534
– – 0.06% 33
2024
Q2 		$1.65M Hold
67,534
– – 0.08% 32
2024
Q1 		$4.85M Hold
67,534
– – 0.19% 25
2023
Q4 		$13.4M Hold
67,534
– – 0.62% 15
2023
Q3 		$8.98M Hold
67,534
– – 0.58% 17
2023
Q2 		$10.1M Hold
67,534
– – 0.54% 19
2023
Q1 		$9.91M Hold
67,534
– – 0.55% 22
2022
Q4 		$10.7M Hold
67,534
– – 0.62% 24
2022
Q3 		$13M Hold
67,534
– – 0.66% 22
2022
Q2 		$9.86M Hold
67,534
– – 0.54% 24
2022
Q1 		$11.9M Sell
67,534
-10,936
-14% -$2.07M 0.39% 27
2021
Q4 		$23.1M Sell
78,470
-10,311
-12% -$2.76M 0.56% 23
2021
Q3 		$22.1M Sell
88,781
-9,821
-10% -$2.6M 0.52% 20
2021
Q2 		$25.1M Sell
98,602
-5,305
-5% -$991K 0.51% 19
2021
Q1 		$18.5M Hold
103,907
– – 0.74% 17
2020
Q4 		$16.4M Sell
103,907
-600
-0.6% -$130K 0.79% 18
2020
Q3 		$26.9M Hold
104,507
– – 1.26% 8
2020
Q2 		$24.3M Hold
104,507
– – 1.12% 9
2020
Q1 		$17.8M Hold
104,507
– – 1.17% 10
2019
Q4 		$23.1M Buy
+104,507
New +$19.2M 1.4% 10

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alphabet Inc's RAPT Position: Q4 2024 in Review

Alphabet Inc sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 67,534 shares — an estimated $1.09M sold.

Alphabet Inc first reported a position in RAPT in Q4 2019 and held it in 20 quarters. The position peaked at $26.9M in Q3 2020. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • Alphabet Inc reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Alphabet Inc sold 67,534 RAPT Therapeutics shares in Q4 2024, an estimated $1.09M.
  • Alphabet Inc first reported a position in RAPT Therapeutics in Q4 2019 and held it in 20 quarters.
  • Alphabet Inc's RAPT Therapeutics position peaked at $26.9M in Q3 2020.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Alphabet Inc's 13F filing for Q4 2024, filed 7 Feb 2025.